Chamber Cardio is a technology company.
Chamber Cardio has raised $68.0M across 2 funding rounds.
Chamber Cardio has raised $68.0M in total across 2 funding rounds.
Chamber Cardio has raised $68.0M in total across 2 funding rounds.
Chamber Cardio's investors include Frist Cressey Ventures, AlleyCorp, American Family Ventures, Black Opal Ventures, Company Ventures, General Catalyst, Healthworx, Optum Ventures, Andreessen Horowitz, B Capital Group, Curie.Bio, Operator Partners.
Chamber Cardio is a technology-enabled platform that empowers cardiology practices to transition to value-based care (VBC) by integrating with existing EHR systems to deliver real-time patient insights, analytics, care coordination tools, and administrative support.[1][2][6] It serves cardiologists, cardiology networks, health plans, and patients with cardiovascular disease, solving key challenges like payer negotiations, care gaps, and administrative burdens to improve outcomes and unlock revenue streams at no upfront cost to practices.[1][2][3] Founded in 2022 and based in Washington, DC, the company raised an $8 million seed round in March 2024 led by General Catalyst, signaling strong early momentum in a sector where VBC adoption among cardiologists lags.[3]
Chamber Cardio was co-founded in 2022 by George Aloth, former president and CEO of a Blue Cross Blue Shield health plan and kidney care VBC executive; Dr. Sameer Sheth, a Yale-trained, board-certified cardiologist practicing at Massachusetts General Hospital (a Harvard affiliate); and Dr. Jeffrey De Flavio, co-founder of Pearl Health and founding CEO of Groups Recover Together.[1][3][4] The idea emerged from frustrations voiced by cardiologists nationwide—lacking specialized tech for population health, struggling with payer negotiations, and facing limited VBC deals—prompting the team to build a clinician-led solution.[3][4] Early traction included partnerships with forward-thinking practices and a seed funding round in 2024, backed by investors like General Catalyst, AlleyCorp, and others, positioning Chamber to scale its network.[3]
Chamber Cardio rides the accelerating shift to value-based care in healthcare, where fee-for-service models are giving way to outcomes-driven payments amid rising cardiovascular disease prevalence from aging populations and chronic conditions.[1][3] Timing is ideal as U.S. cardiology VBC adoption remains low despite payer pressures, creating demand for specialty-specific enablers like Chamber, which differentiates from generalists by focusing on cardio workflows.[3][5] Market forces favoring it include cost-reduction mandates for health plans, tech integration with EHRs, and hybrid care models; it influences the ecosystem by aggregating practices into risk-bearing entities, fostering referrals, and lowering costs while boosting access to quality care.[2][3]
Chamber Cardio is poised to expand its network and VBC contracts, leveraging its $8M funding and clinician credibility to capture share in a fragmented cardiology market.[3] Trends like AI-enhanced analytics, payer consolidation, and chronic disease surges will amplify its growth, potentially evolving it into a dominant risk-bearing platform that redefines cardio economics. As cardiovascular care demands intensify, Chamber's model—empowering practices with tech, teams, and negotiations—positions it to deliver the high-quality, cost-effective outcomes that started its mission.
Chamber Cardio has raised $68.0M across 2 funding rounds. Most recently, it raised $60.0M Series A in February 2026.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 4, 2026 | $60.0M Series A | Frist Cressey Ventures | AlleyCorp, American Family Ventures, Black Opal Ventures, Company Ventures, General Catalyst, Healthworx, Optum Ventures |
| Mar 1, 2024 | $8.0M Seed | AlleyCorp, Andreessen Horowitz, B Capital Group, Curie.Bio, General Catalyst, Operator Partners, Thirty Five Ventures, Transformation Capital, UP.Partners |